ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Meeting Growing National Demand, USAHS Expands MS-SLP Program to Florida and California Campuses

ST. AUGUSTINE, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) has made its renowned Master of Science in Speech-Language Pathology (MS-SLP) Program available at its campuses in St. Augustine, Florida and San Marcos, California. This expansion maintains USAHS' dedication to providing leading-edge health science education and allows students across the U.S. to enter a rapidly growing field with a profound impact on patient lives.

Previously offered only at USAHS’ Texas campuses, the MS-SLP Program has expanded as more and more patients and employers search for qualified speech-language pathologists. As of 2022, there were approximately 168,500 speech-language pathologists in the U.S., and the job market for the profession is projected to grow by 21% from 2022 to 2032 — much faster than the average.

The national need to educate speech-language pathologists is driven by multiple factors, including an aging population with increasing speech and swallowing disorders, and a growing recognition of speech and language issues in children, particularly those on the autism spectrum. Both campuses involved in USAHS’s MS-SLP expansion lie in areas of especially high demand. Employment for speech-language pathologists in both Florida and California is expected to grow by around 30%.

“Our approach entails a unique combination of rigorous academic training, hands-on clinical experience, and innovative learning opportunities,” said Meghan Savage, PhD, CCC-SLP, and Senior Program Director and Associate Professor in the Master of Science in Speech-Language Pathology USAHS. “With these elements balanced across their academic careers, USAHS students in Florida and California will leave these programs ready to succeed in a variety of school and healthcare settings.”

"The education I received at USAHS, especially the value of the residencies, made my transition into the workforce seamless," said Jillian Yudin, Speech-Language Pathologist and graduate of the USAHS MS-SLP Program. "The faculty was committed to my success, and the opportunities for real-world clinical experience gave me the confidence and expertise I need to serve my patients well.”

By making the Master of Science in Speech-Language Pathology Program available at two more of its campuses, USAHS is positioned to continue its mission of funneling exceptional healthcare professionals into communities around the country.

For more information on the expanded USAHS MS-SLP Program, visit https://www.usa.edu/college-of-rehabilitative-sciences/master-science-speech-language-pathology-ms-slp/.

About the University of St. Augustine for Health Sciences
The University of St. Augustine for Health Sciences (USAHS) is a graduate institution dedicated to educating, mentoring and inspiring the next generation of health sciences practitioners. The University offers physical therapy, occupational therapy, speech-language pathology, nursing and healthcare administration graduate programs as well as continuing education. Founded in 1979, USAHS has a network of five campuses that span three states—California, Florida and Texas—and is institutionally accredited by the WASC Senior College and University Commission (WSCUC), 1080 Marina Village Parkway, Suite 500, Alameda, CA 94501, (501) 748-9001, www.wascsenior.org. The University is transforming society by instructing tomorrow’s healthcare providers to be competent, confident and a force for good through its Certified B Corp status. Follow USAHS on Facebook, Instagram, LinkedIn, YouTube and TikTok. To learn more, visit: usa.edu/.

Contact Info:
Caroline Hansen
chansen@wearecsg.com


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.